EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Steatosis, HBV‐related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta‐analysis

Xianhua Mao, Ka Shing Cheung, Chengzhi Peng, Lung-Yi Mak iD, Ho Ming Cheng, James Fung iD, Noam Peleg, Howard H-W Leung, Rajneesh Kumar, Jeong-Hoon Lee iD, Amir Shlomai iD, Man-Fung Yuen und 1 weitere

Hepatology · 2023

DOI: 10.1002/hep.32792 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Hepatology, 2023. Verfasst von Xianhua Mao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Clinical Medicine , The University of Hong Kong , Hong Kong. Hauptthemen laut MEDLINE: Fatty Liver, Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms. Die Arbeit wurde bisher 105-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: NAFLD and chronic hepatitis B (CHB) infection are common etiologies of HCC. The impact of hepatic steatosis on HCC in CHB, as well as its relationship with the development of cirrhosis, fibrosis, and HBsAg seroclearance, remains controversial. Approach and Results: Data from observational studies were collected through PubMed, EMBASE, and the Cochrane Library from inception to February 1, 2022. Outcomes of interest included the association of hepatic steatosis with HCC, cirrhosis, advanced fibrosis, and HBsAg seroclearance, expressed in terms of pooled ORs. Additional subgroup and sensitivity analyses were performed to validate the robustness of findings. A total of 34 studies with 68,268 patients with CHB were included. Hepatic steatosis was associated with higher odds of HCC (OR, 1.59; 95% CI, 1.12–2.26; I 2 = 72.5%), with the association remaining consistent in Asia (OR, 1.56; 95% CI, 1.08–2.25), studies with a median follow‐up duration of ≥5 years (OR, 2.82; 95% CI, 1.57–5.08), exclusion of alcohol use (OR, 1.71; 95% CI, 1.01–2.91), and biopsy‐proven steatosis (OR, 2.86; 95% CI, 1.61–5.06), although no significant association was noted among nucleos(t)ide analogue–treated patients (OR, 1.05; 95% CI, 0.62–1.77). Steatosis was associated with the development of cirrhosis (OR, 1.52; 95% CI, 1.07–2.16; I 2 = 0%) and HBsAg seroclearance (OR, 2.22; 95% CI, 1.58–3.10; I 2 = 49.0%). Conclusions: Hepatic steatosis was associated with an increased risk of HCC and cirrhosis among patients with CHB but with a higher chance of achieving a functional cure, highlighting the importance of identifying concomitant steatosis in CHB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty LiverCarcinoma, HepatocellularLiver CirrhosisLiver NeoplasmsHepatitis B, ChronicHepatitis B virus

Autor:innen und Institutionen

  • Department of Medicine, School of Clinical Medicine , The University of Hong Kong , Hong Kong.
  • Department of Medicine , The University of Hong Kong-Shenzhen Hospital , Shenzhen , China.
  • Li Ka Shing Faculty of Medicine , The University of Hong Kong , Hong Kong.
  • State Key Laboratory of Liver Research , The University of Hong Kong , Hong Kong.
  • Division of Gastroenterology , Rabin Medical Center , Petach Tikva , Israel.
  • Sackler School of Medicine , Tel Aviv University , Tel Aviv , Israel.

ORCID-Profile: Lung-Yi Mak, James Fung, Jeong-Hoon Lee, Amir Shlomai

Zitieren

APA

Mao, X., Cheung, K. S., Peng, C., Mak, L. Y., Cheng, H. M., Fung, J., Peleg, N., Leung, H. H., Kumar, R., Lee, J. H., Shlomai, A., Yuen, M. F., & Seto, W. K. (2023). Steatosis, HBV‐related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta‐analysis. Hepatology. https://doi.org/10.1002/hep.32792

Vancouver

Mao X, Cheung KS, Peng C, Mak LY, Cheng HM, Fung J, et al. Steatosis, HBV‐related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta‐analysis. Hepatology. 2023. doi:10.1002/hep.32792

BibTeX
@article{Mao2023,
  author = {Mao, Xianhua and Cheung, Ka Shing and Peng, Chengzhi and Mak, Lung-Yi and Cheng, Ho Ming and Fung, James and Peleg, Noam and Leung, Howard H-W and Kumar, Rajneesh and Lee, Jeong-Hoon and Shlomai, Amir and Yuen, Man-Fung and Seto, Wai-Kay},
  title = {Steatosis, HBV‐related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta‐analysis},
  journal = {Hepatology},
  year = {2023},
  doi = {10.1002/hep.32792}
}
Kostenlos starten →